Sign Up for Our Newsletter

More

Sign In
Subscribe

Social Media

X-twitter Linkedin
Search
Sign In
Subscribe
Light
Dark
Search
Sign In
Subscribe
Light
Dark
Expandable Search
Sign In
Subscribe
Light
Dark
Sign In
Subscribe
Light
Dark

YOUR AD GOES HERE

BeOne Medicines Raises 2026 Outlook as Brukinsa Drives Second-Quarter Growth
2 months ago
In LeadersPharma Industry UpdatesTop Stories
Inside the Fight Over Sean Kaufman: What a Vaccine Skeptic’s Nomination Reveals About HHS’s Next Chapter
2 months ago
In Breaking NewsLeadersPharma Industry UpdatesTop Stories
No Single Mechanism Solves Epilepsy: What Bright Minds’ BMB-101 Data Tells Us About the Future of Seizure Control
3 months ago
In AI & DataFeatured AnalysisLeadersPeopleResearch Updates
Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals
1 year ago
In Biopharma ManufacturingInnovationLeadersPharma Industry Updates
Clarity Pharmaceuticals Reports Positive Topline Phase II SABRE Trial Data for SAR-Bombesin Diagnostic in Breast Cancer
1 year ago
In Biopharma ManufacturingBreakthroughsClinical TrialsFDA ApprovalsIndustry ConferencesInnovationLeadersResearch UpdatesVenture Capital
June Pharma Highlights: Vaccine Panel Shake-up, Moderna Deal Fallout, and FDA’s AI Adoption
1 year ago
In Featured AnalysisInnovationLeadersPharma Industry Updates
Major Biotech M&A and Global Partnerships Drive Mid-Year Industry Realignment
1 year ago
In DealsInnovationLeadersPartnershipsPharma Industry UpdatesResearch Updates
Hillchol Oral Cholera Vaccine Shows Promise in Phase III Trial in India
1 year ago
In Clinical TrialsInnovationLeaders
Trodelvy plus Keytruda Shows Promise in First-Line PD-L1+ Triple-Negative Breast Cancer
1 year ago
In Clinical TrialsInnovationLeaders
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
In InvestmentsLeadersPartnerships
MAIA Biotechnology Sets Its Sights on Bold Cancer Immunotherapy Milestones for 2025
1 year ago
In Breaking NewsFDA ApprovalsLeadersResearch UpdatesTop Stories
FDA Leadership Change Sparks Industry Concern as Pharma Navigates Regulatory Challenges
1 year ago
In Biopharma HighlightsInnovationLeadersPharma Industry Updates
EMA Greenlights Four New Therapies Including Deqsiga for Immune Disorders
2 years ago
In Breaking NewsLeaders
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
2 years ago
In DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
2 years ago
In AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Clinical Trial Supply Europe 2025: AI, Supply Chain Resilience and Trial Operations Take Center Stage
2 years ago
In Industry ConferencesLeadersPeople
Novartis Accelerates Stroke Prevention Strategy with $3.1B Acquisition of Anthos
2 years ago
In DealsLeadersResearch Updates
FDA Approves First Oral Therapy for Severe Eczema in Adolescents
2 years ago
In Biopharma HighlightsBreaking NewsFDA ApprovalsLeaders
Funding Surge Fuels Innovation: Verdiva, Aviceda, Windward, and Colossal Secure Big Series Rounds in January
2 years ago
In Biopharma HighlightsBreakthroughsDealsFunding RoundsLeadersVenture Capital
Sarepta’s Gene Therapy Elevidys Shows Positive Phase III Results in Duchenne Muscular Dystrophy
2 years ago
In AI & DataClinical TrialsInnovationLeaders
GSK’s Jemperli Receives EMA Approval for First-Line Endometrial Cancer Treatment
2 years ago
In Clinical TrialsFeatured AnalysisLeadersPharma Industry Updates
FDA Approves Datopotamab Deruxtecan (Datroway) for HR-Positive, HER2-Negative Breast Cancer
2 years ago
In FDA ApprovalsInnovationLeadersResearch Updates
Denali, Agios, Cabaletta and Walden Drive Rare Disease and Immuno-Innovations into the Spotlight at JP Morgan Week
2 years ago
In Breaking NewsBreakthroughsIndustry ConferencesLeadersPeopleTop Stories
NHS Launches World-First AI Tool to Predict Type 2 Diabetes Risk From ECG Readings
2 years ago
In InnovationLeaders
FDA Awards RMAT Designation to Mesoblast’s Cell Therapy for Heart Defect, Paving the Way for Pediatric Innovation
2 years ago
In Biopharma HighlightsFDA ApprovalsLeadersPharma Industry UpdatesTop Stories
Pragmatic Trials, Real-World Impact: NIH’s 2024 Push to Redefine Clinical Research
2 years ago
In BreakthroughsFeatured AnalysisLeadersTop Stories
Slate Medicines Emerges With $130 Million to Chase PACAP, a Migraine Target Distinct From CGRP
3 months ago
In DealsFunding RoundsInnovationInvestments
Biotech M&A Surpasses $106 Billion in 2026 as Big Pharma Races to Replenish Pipelines Before Patent Cliffs
3 months ago
In DealsFunding RoundsInvestmentsPartnerships
NewLimit Raises $435 Million Series C to Advance Epigenetic Reprogramming Platform Targeting Age-Related Disease
3 months ago
In Clinical TrialsDealsInvestmentsPartnerships
Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress
1 year ago
In InvestmentsVenture Capital
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
1 year ago
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
1 year ago
In Biopharma HighlightsClinical TrialsInnovationInvestments
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools
1 year ago
In AI & DataInvestments
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial
1 year ago
In InvestmentsPeopleVenture Capital
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
In InvestmentsLeadersPartnerships
Eli Lilly’s $27 Billion Investment Highlights Surge in Biotech Funding and Strategic Partnerships
2 years ago
In DealsInvestmentsPeople
Takeda Seals Major $770 Million Drug Design Partnership While Other Biotech Firms Secure Vital Financing
2 years ago
In Funding RoundsInvestmentsPeopleVenture Capital
Big Bets in Biotech: February 2025 Ushers in Megarounds and Strategic Partnerships
2 years ago
In DealsInvestmentsLeadersPeople
Global AI Summit in Paris Sparks Momentum for Ethical, Inclusive AI in Healthcare and Life Sciences
2 years ago
In AI & DataIndustry ConferencesInnovationInvestmentsLeadersPeople
Atalanta Therapeutics Secures $97M Series B to Advance RNAi Treatments for Epilepsy and Huntington’s Disease
2 years ago
In Clinical TrialsInvestmentsPartnershipsResearch UpdatesVenture Capital
North America Leads January Biotech Funding Round with Nearly $2 Billion Raised, Oncology and Obesity Startups Dominate
2 years ago
In Breaking NewsInvestmentsPartnershipsVenture Capital
Survey Reveals Clinicians Feel Ill-Prepared for Sex Differences in Disease Despite Frequent Observations
2 years ago
In Industry ConferencesInvestmentsPeopleTop Stories
Neumora’s Depression Drug Stumbles in Pivotal Phase 3, Stock Plummets Over 80%
2 years ago
In Clinical TrialsInvestmentsResearch UpdatesTop Stories
New Venture Capital Firms Step In to Fuel Clinical Research Amid Biotech Funding Shift
2 years ago
In Funding RoundsInvestmentsPeopleVenture Capital
Cellarity’s AI-Designed Cell Therapy Enters Phase 1 for Solid Tumors, Backed by $250M Series D
2 years ago
In Biopharma HighlightsClinical TrialsInvestmentsVenture Capital
Celosia Therapeutics Raises $16.75M to Advance Gene Therapy for ALS
2 years ago
In BreakthroughsInvestmentsPartnerships
Strand Therapeutics Raises $153M to Advance mRNA Cancer Therapies
2 years ago
In InvestmentsPeopleResearch Updates
AI-Powered Drug Discovery Accelerates Biopharma Innovation and Reduces R&D Costs
2 years ago
In Featured AnalysisInvestmentsPartnershipsResearch UpdatesTechnologyTop Stories
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS
2 years ago
In FDA ApprovalsInvestmentsPharma Industry Updates
Neuronetics Q2 Update Tests the Scale Economics of Interventional Psychiatry
1 month ago
In Featured AnalysisInnovationResearch UpdatesTop Stories
Moderna Starts Human Trial of mRNA Vaccine Against Bundibugyo Ebola
2 months ago
In Breaking NewsClinical TrialsFeatured AnalysisInnovationTop Stories
China’s Biotech Model Is Moving From Asset Export to Integrated Drug Building
2 months ago
In AI & DataBiopharma ManufacturingFeatured AnalysisInnovationPartnershipsTop Stories
Bambusa’s Dual-Target Antibody Shows Early Atopic Dermatitis Activity After First Dose
2 months ago
In Breaking NewsClinical TrialsInnovationResearch Updates
IDEAYA Expands IDE892 Study in MTAP-Deleted Pancreatic and Lung Cancers
2 months ago
In Biopharma HighlightsClinical TrialsInnovationResearch Updates
MannKind Wins FDA Approval for Furoscix ReadyFlow, Cutting Heart Failure Diuretic Therapy From Five Hours to Ten Seconds
2 months ago
In Breaking NewsFDA ApprovalsInnovation
Celea Therapeutics Launches With $180 Million to Challenge Pirfenidone in IPF
3 months ago
In DealsFunding RoundsResearch UpdatesStartups
Slate Medicines Emerges With $130 Million to Chase PACAP, a Migraine Target Distinct From CGRP
3 months ago
In DealsFunding RoundsInnovationInvestments
FDA Extends Casgevy’s Reach to Children as Young as Two, Reshaping the Sickle Cell Treatment Landscape
3 months ago
In Breaking NewsFDA ApprovalsInnovationPharma Industry Updates
Australia’s TGA Grants Conditional Approval to Iovance’s Lifileucel — A First for T Cell Therapy in Solid Tumour Oncology
3 months ago
In BreakthroughsClinical TrialsFeatured AnalysisInnovation
Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study
1 year ago
In Clinical TrialsStartups
New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease
1 year ago
In Breaking NewsBreakthroughsInnovationTop Stories
APG777 Shows Strong Skin Clearance in Phase 2 Trial for Moderate-to-Severe Atopic Dermatitis
1 year ago
In Clinical TrialsInnovationTop Stories
Biodexa Pharmaceuticals Reports Interim Results Highlighting Strategic Advances in Rare Disease Pipeline and Clinical Progress
1 year ago
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
Atea Pharmaceuticals Advances Global Phase 3 HCV Program with First Patient Dosed in C-FORWARD Outside North America
1 year ago
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Hikma Pharmaceuticals Invests $1 Billion to Expand U.S. Generic Drug Manufacturing Capabilities and Announces Sustainability Goals
1 year ago
In Biopharma ManufacturingInnovationLeadersPharma Industry Updates
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
1 year ago
In Biopharma HighlightsInnovationInvestmentsPeoplePharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
1 year ago
In Biopharma HighlightsClinical TrialsInnovationInvestments
Viking Therapeutics Launches Phase 3 VANQUISH Program for VK2735 in Obesity and Type 2 Diabetes
1 year ago
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Metabolics Pharma Announces Positive Topline Results from Phase 1a Clinical Trial of ENT-03 in Obese and Diabetic Subjects
1 year ago
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones
1 year ago
In Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials, Offering New Hope for Obesity and Type 2 Diabetes Management
1 year ago
In BreakthroughsClinical TrialsInnovationPharma Industry UpdatesResearch Updates
Ocular Therapeutix Advances OTX-TKI Axitinib Hydrogel with Positive Phase 1/2 and Registrational Trial Data
1 year ago
In Biopharma ManufacturingClinical TrialsInnovationPharma Industry UpdatesTechnology
Zealand Pharma Reports Positive Phase 1b Results for Dual GLP-1/GLP-2 Agonist Dapiglutide in Obesity and Metabolic Disease
1 year ago
In Biopharma HighlightsBreakthroughsClinical TrialsInnovationResearch Updates
AbbVie Provides Update on VERONA Trial Evaluating Venetoclax in Newly Diagnosed Higher-Risk Myelodysplastic Syndromes
1 year ago
In Clinical TrialsInnovationPharma Industry UpdatesResearch Updates
CSL’s ANDEMBRY™ Gains FDA Approval as First Prophylactic Therapy Targeting Factor XIIa for Hereditary Angioedema
1 year ago
In Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
Mereo and Sentynl Strike Alvelestat Option Deal in Alpha-1 Lung Disease
1 month ago
In Breaking NewsPartnershipsPharma Industry UpdatesResearch UpdatesTop Stories
China’s Biotech Model Is Moving From Asset Export to Integrated Drug Building
2 months ago
In AI & DataBiopharma ManufacturingFeatured AnalysisInnovationPartnershipsTop Stories
The Biohaven Verdict Sends a Warning Through Biotech’s Confidential Deal Rooms
2 months ago
In Featured AnalysisPartnershipsPharma Industry UpdatesTop StoriesVenture Capital
Biotech M&A Roars Back: Why 2026 Is Already the Best Dealmaking Year in Seven Years
2 months ago
In Featured AnalysisPartnershipsTop StoriesVenture Capital
Epcoritamab Clears Phase 3 Bar in Relapsed Large B-Cell Lymphoma
3 months ago
In Clinical TrialsPartnershipsResearch Updates
Vertex’s Casgevy Clears FDA Hurdle for Youngest Sickle Cell Patients
3 months ago
In Breaking NewsBreakthroughsFDA ApprovalsPartnerships
Epcoritamab Combination Hits Progression-Free Survival Mark in Phase 3 Lymphoma Trial, Genmab and AbbVie Report
3 months ago
In BreakthroughsClinical TrialsPartnershipsResearch Updates
Biotech M&A Surpasses $106 Billion in 2026 as Big Pharma Races to Replenish Pipelines Before Patent Cliffs
3 months ago
In DealsFunding RoundsInvestmentsPartnerships
Eli Lilly’s $7.8 Billion Centessa Deal Extends Neuroscience Ambitions into Orexin Signalling and Excessive Daytime Sleepiness
3 months ago
In PartnershipsResearch Updates
Isomorphic Labs Closes $2.1 Billion Series B to Push AI-Designed Drugs Toward First Clinical Trials
3 months ago
In DealsFunding RoundsPartnerships
Biotech M&A Reaches $106 Billion in 2026 as Patent Cliff Pressure and Recovering Markets Drive Record Deal Pace
3 months ago
In DealsFunding RoundsPartnerships
GSK Bets $10.6 Billion on Lung Cancer as Nuvalent Acquisition Reshapes Oncology Pipeline
3 months ago
In DealsFunding RoundsPartnershipsTop Stories
NewLimit Raises $435 Million Series C to Advance Epigenetic Reprogramming Platform Targeting Age-Related Disease
3 months ago
In Clinical TrialsDealsInvestmentsPartnerships
CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug
1 year ago
In Biopharma HighlightsPartnerships
Atea Pharmaceuticals Advances Global Phase 3 HCV Program with First Patient Dosed in C-FORWARD Outside North America
1 year ago
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
MaaT Pharma Delivers Business Update Amid Positive Clinical and Commercial Milestones
1 year ago
In Biopharma HighlightsClinical TrialsInnovationPartnershipsPharma Industry Updates
Clarity Pharmaceuticals and SpectronRx Announce Major U.S. Manufacturing Deal for 64Cu-SAR-bisPSMA Radiopharmaceutical
1 year ago
In Biopharma ManufacturingClinical TrialsPartnershipsPharma Industry UpdatesTechnology
Innovative Biotech Collaborations and Cutting-Edge Clinical Data Spotlight June 11 Advances
1 year ago
In Clinical TrialsIndustry ConferencesInnovationPartnershipsPharma Industry UpdatesResearch Updates
June Biotech Momentum: Innovation, Regulatory Shifts, and Strategic Collaborations
1 year ago
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Cell and Gene Therapy Advances Highlighted in Recent Trials and Industry Collaborations
1 year ago
In Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
New Biotech M&A, Radiopharma Advances, and Global Partnerships Shape Early June Momentum
1 year ago
In Clinical TrialsFunding RoundsInnovationPartnershipsPharma Industry UpdatesResearch Updates
Major Biotech M&A and Global Partnerships Drive Mid-Year Industry Realignment
1 year ago
In DealsInnovationLeadersPartnershipsPharma Industry UpdatesResearch Updates
Immunic, PDS Biotech, and Global Partnerships Define Early June Biotech Pulse
1 year ago
In Biopharma HighlightsClinical TrialsFunding RoundsInnovationPartnershipsPharma Industry Updates
Australia Boosts Brain Cancer Research with $5.9 Million Grant for Innovative Chair
1 year ago
In Biopharma HighlightsPartnershipsPeople
Big Bets and Strategic Moves Drive Biotech Investment in 2025
1 year ago
In InvestmentsLeadersPartnerships
Taiho Pharmaceutical Acquires Araris Biotech to Accelerate Next-Generation ADC Drug Development
2 years ago
In InnovationPartnershipsPharma Industry UpdatesResearch Updates